Next Article in Journal
PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression
Previous Article in Journal
Co-Functionalization of Gold Nanoparticles with C7H2 and HuAL1 Peptides: Enhanced Antimicrobial and Antitumoral Activities
Previous Article in Special Issue
Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems
Article

Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment

1
Federal Research Center Crystallography and Photonics, Russian Academy of Sciences, 119991 Moscow, Russia
2
Department of Biomedical Engineering, Sechenov First State Medical University, 119991 Moscow, Russia
3
Center for Neurobiology and Brain Restoration (CNBR), Skolkovo Institute of Science and Technology, 143025 Moscow, Russia
4
The Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia
*
Author to whom correspondence should be addressed.
Academic Editor: Korbinian Löbmann
Pharmaceutics 2022, 14(7), 1325; https://doi.org/10.3390/pharmaceutics14071325
Received: 4 May 2022 / Revised: 30 May 2022 / Accepted: 18 June 2022 / Published: 23 June 2022
Beneficial features of biocompatible high-capacity UiO-66 nanoparticles, mesoporous SiO2, and folate-conjugated pluronic F127 were combined to prepare the core–shell [email protected]2/F127-FA drug delivery carrier for targeted cellular uptake in cancer treatment. UiO-66 and UiO-66-NH2 nanoparticles with a narrow size and shape distribution were used to form a series of core–shell [email protected]2 structures. The duration of silanization was varied to change the thickness of the SiO2 shell, revealing a nonlinear dependence that was attributed to silicon penetration into the porous MOF structure. Doxorubicin encapsulation showed a similar final loading of 5.6 wt % for both uncoated and silica-coated particles, demonstrating the potential of the nanocomposite’s application in small molecule delivery. Silica coating improved the colloidal stability of the composites in a number of model physiological media, enabled grafting of target molecules to the surface, and prevented an uncontrolled release of their cargo, with the drawback of decreased overall porosity. Further modification of the particles with the conjugate of pluronic and folic acid was performed to improve the biocompatibility, prolong the blood circulation time, and target the encapsulated drug to the folate-expressing cancer cells. The final DOX-loaded [email protected]2/F127-FA nanoparticles were subjected to properties characterization and in vitro evaluation, including studies of internalization into cells and antitumor activity. Two cell lines were used: MCF-7 breast cancer cells, which have overexpressed folate receptors on the cell membranes, and RAW 264.7 macrophages without folate overexpression. These findings will provide a potential delivery system for DOX and increase the practical value of MOFs. View Full-Text
Keywords: nano-MOF; nanoparticles; UiO-66; MOF; silanization; silica shell; tumor targeting; folate receptors; chemotherapy; doxorubicin nano-MOF; nanoparticles; UiO-66; MOF; silanization; silica shell; tumor targeting; folate receptors; chemotherapy; doxorubicin
Show Figures

Graphical abstract

MDPI and ACS Style

Trushina, D.B.; Sapach, A.Y.; Burachevskaia, O.A.; Medvedev, P.V.; Khmelenin, D.N.; Borodina, T.N.; Soldatov, M.A.; Butova, V.V. Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment. Pharmaceutics 2022, 14, 1325. https://doi.org/10.3390/pharmaceutics14071325

AMA Style

Trushina DB, Sapach AY, Burachevskaia OA, Medvedev PV, Khmelenin DN, Borodina TN, Soldatov MA, Butova VV. Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment. Pharmaceutics. 2022; 14(7):1325. https://doi.org/10.3390/pharmaceutics14071325

Chicago/Turabian Style

Trushina, Daria B., Anastasiia Y. Sapach, Olga A. Burachevskaia, Pavel V. Medvedev, Dmitry N. Khmelenin, Tatiana N. Borodina, Mikhail A. Soldatov, and Vera V. Butova. 2022. "Doxorubicin-Loaded Core–Shell [email protected]2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment" Pharmaceutics 14, no. 7: 1325. https://doi.org/10.3390/pharmaceutics14071325

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop